BarryGreenbergMD

PubMed

• 407 citations
  A Dose-Dependent Increase in Mortality with Vesnarinone among Patients with Severe Heart Failure
  Jay N. Cohn, Sidney Goldstein, Barry H. Greenberg, Beverly H. Lorell, Robert C. Bourge
  The New England Journal of Medicine. 1998-12-17
• 149 citations
  The MOGE(S) classification for a phenotype-genotype nomenclature of cardiomyopathy: endorsed by the World Heart Federation.
  Eloisa Arbustini, Navneet Narula, G. William Dec, K. Srinath Reddy, Barry H. Greenberg
  Journal of the American College of Cardiology. 2013-12-03
• 3 citations
  Reply: The MOGE(S) classification for a phenotype-genotype nomenclature of cardiomyopathy: more questions than answers?
  Eloisa Arbustini, Navneet Narula, G. William Dec, K. Srinath Reddy, Barry H. Greenberg
  Journal of the American College of Cardiology. 2014-06-17

Journal Articles

• Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease  
  Mandeep R Mehra, Barry Greenberg, The New England Journal of Medicine
• The hemodynamic and metabolic effects of glucagon in patients with chronic valvular heart disease.  
  Greenberg BH, Tsakiris AG, Moffitt EA, Frye RL, Mayo Clin Proc
• Oral hydralazine therapy for chronic refractory heart failure.  
  Chatterjee K, Parmley WW, Massie B, Greenberg BH, Werner J, Klausner S, Norman A, Circulation
• Primary type V hyperlipoproteinemia.  
  Greenberg BH, Blackwelder W, Levy RI, Ann Intern Med
• Sudden death in infective endocarditis.  
  Greenberg BH, Chatterjee K, Hoffman P, Miller M, Schiller N, Chest
• Hemodynamic advantages of combined oral hydralazine and non-parenteral nitrates in vasodilator therapy of chronic heart failure.  
  Massie B, Chatterjee K, Werner J, Greenberg BH, Hart R, Parmley WW, Am J Cardiol
• Thallium 201 myocardial perfusion scintigraphy for the evaluation of post coronary bypass patients.  
  Greenberg BH, Botvinick EH, Shames DH, Hart R, Werner JA, Brundage BH, Chatterjee K, Parmley WW, Am J Cardiol
• Beneficial effects of hydralazine in severe mitral regurgitation.  
  Greenberg BH, Massie BM, Brundage BH, Botvinick EH, Parmley WW, Circulation
• Relationship of regional myocardial perfusion to segmental wall motion: A physiologic basis for understanding the presence and reversibility of asynergy.  
  Massie BM, Botvinick EH, Brundage BH, Greenberg BH, Shames D, Gelberg H, Circulation
• The influence of filling pressure on atrial contribution to cardiac output.  
  Greenberg BH, Chatterjee K, Parmley WW, Werner JA, Norman A, Am Heart J
• Evaluation of Left Ventricular Volume, Ejection Fraction and Segmental Wall Motion by Gated Radionuclide Angiography.  
  Greenberg BH, Drew D, Werner J, Botvinick E, Shames D, Clin Nucl Med
• Results of aortic valve replacement in patients with aortic stenosis and aortic incompetence and impaired left ventricular function.  
  Greenberg BH, Smith N, Clark DG, Rahimtoola SH, Coeur
• Beneficial effects of afterload reduction therapy in patients with congestive heart failure and moderate aortic stenosis.  
  Greenberg BH, Massie B, Circulation
• Beneficial effects of hydralazine on rest and exercise hemodynamics in patients with chronic severe aortic insufficiency.  
  Greenberg BH, DeMots H, Murphy E, Rahimtoola SH, Circulation
• Long-term vasodilator therapy in aortic insufficiency. Evidence for regression of left ventricular dilation and hypertrophy and improved systolic pump function.  
  Greenberg BH, Rahimtoola SH, Ann Intern Med
• Mechanism for improved cardiac performance with arteriolar dilators in aortic insufficiency.  
  Greenberg BH, DeMots H, Murphy E, Rahimtoola SH, Circulation
• Preoperative criteria predictive of late survival following valve replacement for severe aortic regurgitation.  
  Greves J, Rahimtoola SH, McAnulty JH, DeMots H, Clark DG, Greenberg BH, Starr A, Am Heart J
• Vasodilator therapy for valvular heart disease.  
  Greenberg BH, Rahimtoola SH, JAMA
• Results of long-term vasodilator therapy in patients with refractory congestive heart failure.  
  Walsh WF, Greenberg BH, Circulation
• Hydralazine therapy in aortic insufficiency.  
  Greenberg BH, Primary Cardiol
• Safety and Efficacy Safety and Efficacy of Diltiazem HCL for the treatment of stable angina pectoris.  
  Strauss WE, McIntyre KM, Parisi AF, Shapiro W and Investigators, Am J Cardiol
• Effects of arterial dilation on cardiac performance during rest and exercise in patients with mitral regurgitation.  
  Greenberg BH, DeMots H, Murphy E, Rahimtoola SH, Circulation
• Acute effects of alcohol in patients with congestive heart failure.  
  Greenberg BH, Schutz R, Grunkemeier GL, Griswold HE, Ann Intern Med
• Deleterious effects of hydralazine in patients with pulmonary hypertension.  
  Packer M, Greenberg BH, Massie B, Dash H, N Engl J Med
• The preoperative evaluation in patients with endocarditis: Is cardiac catheterization necessary?  
  Hosenpud JD, Greenberg BH, Chest
• Join now to see all

Books/Book Chapters

• Heart Failure as a consequence of Valvular Disease. 
  Chapter: Congestive Heart Failure 
  Page 336 - 353McKenna WJ, Pollerin D, Mahon NG, and Greenberg BHEditors: Hosenpud JD and Greenberg BH.Lippincott, Williams, and Wilkins, Philadelphia, PA
• Vasodilator therapy of chronic aortic insufficiency. 
  Chapter: Aortic Insufficiency 
  Page 143 - 160Greenberg BEditors: Gaasch W and Levine H.Kluwer Academic Publishers, Boston
• Pro Digitalis glycosides are useful in the treatment of congestive heart failure. 
  Chapter: Debates in Cardiology 
  Page 118 - 137Greenberg BEditors: Fortuin, N.Year Book Medical Publishers, Boston, Chicago
• Heart Failure in Patients with Chronic Renal Failure. 
  Chapter: Heart Failure Therapy: Special Therapeutic Consideration in Heart Failure 
  Page 107 - 120Hassankhani A, Sawney N and Greenberg BHEditors: Willenheimer R and Swedberg K.Martin Dunitz, Ltd, London
• Cardiac Remodeling. 
  Chapter: Molecular Mechanisms for Cardiac Hypertrophy and Failure 
  Page 247 - 264Greenberg BHEditors: Walsh A.Taylor and Francis, Milton Park, Abington, Oxon, U.K
• The Renin-Angiotensin System in Cardiac Remodeling. 
  Chapter: Myocardial Remodeling: Mechanisms and Treatment 
  Page 247 - 264Greenberg BHEditors: Greenberg BH.Taylor and Francis Group, New York, NY
• Future Directions in Cardiac Remodeling. 
  Chapter: Myocardial Remodeling: Mechanisms and Treatment 
  Page 553 - 558Greenberg BHEditors: Greenberg BH.Taylor and Francis Group, New York, NY
• Role of the Renin-Angiotensin Aldosterone System. 
  Chapter: Congestive Heart Failure 
  Page 167 - 177Greenberg BHEditors: Hosenpud J and Greenberg B.Lippincott, Williams and Wilkins, Philadelphia, PA
• What Does the Future Hold? 
  Chapter: Congestive Heart Failure 
  Page 829 - 833Hosenpud, JD and Greenberg, BHEditors: Hosenpud, JD and Greenberg BH.Lippincott, Williams and Wilkins, Philadelphia, PAEdition 3rd,
• Acquired aortic valve disease. 
  Chapter: Valvular Heart Disease 
  Page 147 - 173Greenberg BHEditors: BH Greenberg and E Murphy.John Wright (PSG) Boston
• The Medical Management of Chronic Heart Failure in Patients with Systolic Dysfunction. 
  Chapter: Congestive Heart Failure 
  Page 621 - 646Greenberg BHEditors: Hosenpud JD and Greenberg BH.Lippincott, Williams and Wilkins, Philadelphia, PA
• How to Use Neurohormonal Antagonists in Heart Failure. 
  Chapter: Heart Failure: A Practical Approach to Treatment 
  Page 105 - 125Fraley A, Greenberg BHEditors: Abraham WT, Henry Krum.The McGraw –Hill Companies Inc, New York, NY
• Treatment of endocarditis. 
  Chapter: Conn's Current Therapy 
  Page 218 - 225Larsen G, Greenberg BEditors: R. Rakel.W.B. Saunders Co, Philadelphia
• Does the patient with infective endocarditis and a large vegetation on the mitral or aortic valve need surgery? 
  Chapter: Dilemmas in Clinical Cardiology 
  Page 215 - 228Lewis HS, Greenberg BHEditors: M. Cheitlin.Cardiovasc Clin, Philadelphia
• Refractory Heart Failure. 
  Chapter: Heart Failure Management 2000 
  Page 199 - 213Hermann DD, Greenberg BHEditors: Sharpe N.Martin Dunitz Ltd, London
• Effects of dietary fish oil in experimental models of atherosclerosis. 
  Chapter: Fish oil and blood vessel wall interactions 
  Greenberg BEditors: P.M. Vanhoutte and Ph. Douste-Blazy.John Libbey Eurotext, Paris
• Medical therapy for patients with aortic insufficiency. 
  Chapter: Cardiology Clinics 
  Page 255 - 270Greenberg BEditors: B. Carabello.W.B. Saunders Co, Philadelphia
• Evolution of concepts of myocardial function in the treatment of congestive heart failure in man. 
  Chapter: Congestive Heart Failure 
  Page 3 - 10Gorlin R, Hosenpud J, Greenberg BEditors: Hosenpud J and Greenberg B.Springer-Verlag, New York
• Clinical Assessment of Heart Failure. 
  Chapter: Braunwald’s Heart Disease 
  Page 505 - 516Greenberg B, Kahn AMElsevier, PhiladelphiaEdition 9th,
• Contemporary Cardiovascular Continuum. 
  Greenberg BH, Barnard D., Amsterdam EA, Liebson P, Grundy SMHandbooks in Health Care Co, Newtown, PA
• Management of Heart Failure. 
  Greenberg BH, Barnard DD, Narayan SM, Teerlink JRWiley-Blackwell, A John Wiley & Sons, Ltd, Chichester, West Sussex, UK
• Valvular Heart Disease. 
  Greenberg BH, Murphy EPSG Publishing Company, Littleton, Massachusetts
• Congestive Heart Failure: Pathophysiology, Diagnosis, and Comprehensive Approach to Management. 
  Hosenpud JD, Greenberg BHSpringer-Verlag, New YorkEdition 1st,
• Cardiac Remodeling: Mechanisms and Treatment. 
  Greenberg, BHMarcel Dekker, Philadelphia, PA
• Management of post-infarction congestive heart failure. 
  Chapter: Coronary Artery Disease 
  Page 419 - 436Greenberg BHEditors: JD Bristow and W Connor.J. B. Lippincott, Philadelphia
• Join now to see all

Abstracts/Posters

• Characteristics of VIP and PHI relaxation of bovine and human pulmonary artery.
  Greenberg B, Rhoden K, Barnes P, Thorax
• Characteristics and prognosis of patients with preserved versus impaired left ventricular systolic function.
  Ghali JK, Weiner DH, Quinones MA, Greenberg BH, Pratt CM for the SOLVD Registry Investigators, Circ
• Modulations of mRNA expression for angiotensin II (Ang II) receptor subtypes (AT1A and AT1B) analyzed by quantitative RT-PCR quantification.
  Llorens-Cortes C, Greenberg B, Huang H, Monnot C, Michel JB, Corvol P, FASEB
• Effects of long-term enalapril therapy on echocardiographic variables in SOLVD patients.
  Greenberg B, Quinones M, Koilpillai C, Limacher M, Schindler D, Shelton D for the SOLVD investigators, Circulation
• Effects of chronic captopril therapy on endothelium-derived relaxing factor in heart failure.
  Ontkean M, Perkins K, Gay R, Greenberg B, Clin Res
• Factors influencing the response to long-term arterial dilator therapy for aortic insufficiency.
  Greenberg B, Massie B, Bristow JD, Cheitlin M, Siemienczuk D, Topic N, Wilson R, Thomas D, Circulation
• Coronary artery relaxant effects of calcitonin gene-related peptide and vasoactive intestinal peptide.
  Greenberg B, Rhoden K, Barnes P, Fed Proc
• Endothelial relaxant factor is present in human pulmonary artery.
  Greenberg B, Rhoden K, Barnes P, Circulation
• Relationship between ejection fraction and the end-systolic pressure-volume ratio in chronic aortic regurgitation.
  Wilson RA, Greenberg B, Siemienczuk D, Bristow D, Cheitlin M, Broudy D, Krishnamurthy G, Thomas D, Circulation
• Reproducibility at rest and exercise radionuclide ventriculography in chronic aortic regurgitation.
  Cornyn J, Massie BM, Greenberg B, Loge D, Thomas D, Bristow J D, Cheitlin M, Krishnamurthy G, Circulation
• Quantitation of chronic aortic insufficiency using color doppler flow mapping.
  Bouchard A, Yock PG, Schiller NB, Newlands JB, Massie BM, Botrimik EH, Greenberg B, Cheitlin MD, Circulation
• VIP causes endothelium independent relaxation in bovine and human pulmonary artery.
  Greenberg B, Rhoden K, Barnes P, Circulation
• Echocardiographic predictors of one-year clinical outcome in the Study of Left Ventricular Dysfunction (SOLVD) Trial and Registry: An analysis of 1172 patients.
  Quiñones MA, Weiner DH, Shelton BJ, Greenberg BH, Limacher MC, Koilpillai C, Shindler DM, Yusuf S for the SOLVD Investigators, Circ
• Evidence of endothelial cell dependent relaxation of pulmonary artery in man.
  Greenberg B, Rhoden K, Barnes P, Thorax
• Effects of static versus dynamic exercise on cardiac performance in patients with congestive heart failure.
  Broudy D, Greenberg B, Siemienczuk D, Clin. Res
• Improved cardiac performance in patients with heart failure following meal ingestion.
  Siemienczuk D, Greenberg B, Broudy D, Circulation
• Rat pulmonary artery demonstrates a biphasic response to anoxia.
  Greenberg B, Kishiyama S, Circulation
• Endothelium-derived relaxation factor (EDRF) is diminished in congestive heart failure.
  Ontkean M, Greenberg B, Lewis H, Gay R, Circulation
• Abrupt cessation of hydralazine in chronic aortic insufficiency does not result in clinical deterioration.
  Siemienczuk D, Greenberg B, Morris C, Wilson R, Massie B, Topic N, Bristow JD, Cheitlin M, Circulation
• Effects of long-term vasodilator therapy on left ventricular size and function during exercise in chronic aortic insufficiency.
  Greenberg B, Siemienczuk D, Massie B, Wilson R, Bristow JD, Cheitlin M, Circulation
• Factors associated with progression to aortic valve replacement in chronic aortic insufficiency.
  Siemienczuk D, Greenberg B, Morris C, Topic N, Wilson R, Bristow JD, Cheitlin M, Massie B, Clin Res
• Relationship of aortic compliance and left ventricular performance in patients with chronic aortic insufficiency.
  Perlmutter N, Wilson R, McDonald R, Greenberg B, Nguyen L, Jacobson N, Siemienczuk D, Massie B, Cheitlin M, Bristow JD, Clin Res
• Chronic hydralazine therapy leads to improvement in electrocardiographic abnormalities in patients with chronic aortic insufficiency.
  Jacobson N, Perlmutter N, Wilson R, Siemienczuk D, Szlachcic J, Topic N, Bristow JD, Cheitlin M, Massie B, Greenberg B, Clin Res
• Lidocaine induced coronary artery vasodilation: A dose dependent phenomenon.
  Edgar S, Perlmutter N, Tanz R, Greenberg B, Wilson R, Clin Res
• Characteristics of VIP and PHI relaxation of bovine and human pulmonary artery.
  Greenberg B, Rhoden K, Barnes P, British Thoracic Society, York, England
• Join now to see all

Lectures

• HFSA Board Review Course 2012: Advanced Heart Failure and Transplant Cardiology 
  Heart Failure Society of America, Bloomington, Minnesota - 9/27/2012
• Current concepts in clinical cardiology. 
  Ashland, Oregon
• The use of vasodilators in congestive heart failure. 
  Vancouver, Washington
• Clinical spectrum of coronary artery spasm. 
  Portland, Oregon
• Cardiovascular manifestations of Marfan's disease. 
  Portland, Oregon
• Congestive heart failure and the use of vasodilators. 
  Allenmore Community Hospital, Tacoma, Washington
• Hemodynamic Workshop. 
  Portland, Oregon
• Vasodilator drugs in the treatment of congestive heart failure. 
  Portland, Oregon
• Novel Neurohormonal Strategies in the Treatment of Heart Failure. 
  Fresno Community Hospital, Fresno, CA
• New Paradigms in the Treatment of Heart Failure. 
  Sharp Chula Vista Medical Center
• Therapeutic Strategies in the Management of Structural Heart Disease in Asymptomatic Heart Failure Patients. 
  Boca Raton, FL
• Progression for Valve Disease to Heart Failure: Natural History and Prevention. 
  Boca Raton, FL
• Case Discussion Panel. 
  Boca Raton, FL
• Treatment of Heart Failure. 
  Scripps Mercy, San Diego, CA
• Emerging Concepts in Beta Blocker Therapy in Heart Failure. 
  Providence St. Vincent Medical Center, Portland, OR
• Cardiac Remodeling-Mechanisms and Therapeutic Implications. 
  UCSF Medical Center-Moffitt Long Hospital, San Francisco, CA
• 2002 Update in the Management of Heart Failure. 
  Loews Coronado Bay Resort, San Diego, CA
• Recognizing Patients at Risk and Strategies for Preventing Heart Failure. 
  HFSA Symposium, Heart Failure 2002: Update for the Primary Care Physician
• New Advances in the Treatment of Acute Congestive Heart Failure. 
  La Mesa, CA
• Emerging Role of Beta-Blockers in Heart Failure. 
  California Pacific Medical Center. San Francisco, CA
• Cardiac Remodeling- Clinical Insights and Mechanisms. 
  University of California, Irvine. Irvine, CA
• New Treatments for Congestive Heart Failure. 
  Hilton, San Diego, CA
• 2002 Update in the Management of CHF. 
  St. Bernadine Medical Center, San Bernardino, CA
• Cardiac Remodeling: Implications Regarding Heart Failure Progression and Treatment. 
  Saint Luke’s Hospital, Kansas City, MO
• Cardiac Remodeling: Implications Regarding Heart Failure Progression and Treatment. 
  The Fairmont Kansas City at the Plaza, Kansas City, MO
• Join now to see all

Other

• A Consensus Proposal for an Early Enrollment Strategy in Acute Heart Failure Syndromes Clinical Trials: The Rationale, Challenges, and Opportunities. 
  Pang PS, Douglas K, Fonarow GC, Sopko G, Greenberg B, Collins SP, Storrow AB, Peacock WF, Aldeen AZ, Levy P, Diercks D, Brandimarte F, Filippatos G, Mebazaa A, Mehra M...
• Clinical Trials in Heart Failure. A Continuing Medical Education Slide Lecture Program. 
  Pitt B, Greenberg B, Konstam M and Pina, I, Dannemiller Memorial Education Foundation and Health Education Alliance, Inc
• Audio-Digest in Internal Medicine. 
  Greenberg BH, Congestive Heart Failure
• Audio-Digest in Internal Medicine. Heart Failure 2003: Update for the Primary Care Physician-Identifying and Treating the Patient at Risk. 
  Greenberg BH
• Audio-Digest Family Practice. 
  Greenberg, BH
• Audio-Digest in Internal Medicine. 
  Greenberg, BH, Heart Failure: How experts handle challenging cases: case presentation 1
• Evidence-based Approach for the Management of Post-myocardial Infarction With or Without Left Ventricular Dysfunction. 
  Greenberg, BH, Millennium CME Institute, Inc
• Heart Failure: Dealing With Difficult Cases. 
  Greenberg BH, Audio-Digest in Family Practice
• Heart Failure: Congestive Heart Failure Update. 
  Greenberg BH, Audio-Digest in Family Practice
• Influence if Diabetes Mellitus on Characteristics and Outcomes in Patients Hospitalized with Heart Failure. 
  Greenberg, BH, Abraham, WT, Albert, NM, Gattis Stough, WA, Gheorghiade, M, O’Connor, CM, She, L, Yancy, CW, Young, JB, Fonarow, GC
• Join now to see all